Awards for “mckesson”
25 awards on this page · sorted by amount · page 2
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| 36C77020K0085 | MCKESSON CORPORATION | Department of Veterans Affairs | $958.01M | 2019-10-01 | 2019-12-31 | 325412 | EXPRESS REPORT: PHARMACY PRIME VENDOR CMOP FY20 OCT 1, 2019 TO DEC 31, 2019 CONTRACT VA797P-12-D-0001 |
| 36C24024K1012 | MCKESSON CORPORATION | Department of Veterans Affairs | $953.24M | 2024-09-01 | 2024-09-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 SEPTEMBER |
| 36C24024K1011 | MCKESSON CORPORATION | Department of Veterans Affairs | $943.8M | 2024-08-01 | 2024-08-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 AUGUST |
| 36C24025K1002 | MCKESSON CORPORATION | Department of Veterans Affairs | $911.98M | 2024-11-01 | 2024-11-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 NOVEMBER |
| 36C24023K1012 | MCKESSON CORPORATION | Department of Veterans Affairs | $901.98M | 2023-09-01 | 2023-09-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 SEPTEMBER |
| 36C24023K1011 | MCKESSON CORPORATION | Department of Veterans Affairs | $884.91M | 2023-08-01 | 2023-08-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 AUGUST |
| 36C77018K0991 | MCKESSON CORPORATION | Department of Veterans Affairs | $869.06M | 2018-07-01 | 2018-09-30 | 325412 | EXPRESS REPORT: PHARMACY PRIME VENDOR CMOP FY18 JUL 1, 2018 TO SEP 30, 2018 CONTRACT VA797P-12-D-0001 |
| 36C24024K1006 | MCKESSON CORPORATION | Department of Veterans Affairs | $851.41M | 2024-03-01 | 2024-03-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MARCH |
| 36C24024K1009 | MCKESSON CORPORATION | Department of Veterans Affairs | $838.79M | 2024-06-01 | 2024-06-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JUNE |
| 36C77018K0157 | MCKESSON CORPORATION | Department of Veterans Affairs | $838.22M | 2017-07-01 | 2017-09-30 | 325412 | EXPRESS REPORT: PHARMACY PRIME VENDOR CMOP FY17 JUL 1, 2017 TO SEP 30, 2017 CONTRACT VA797P-12-D-0001 |
| 36C24022K1012 | MCKESSON CORPORATION | Department of Veterans Affairs | $837.78M | 2022-09-01 | 2022-09-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 SEPTEMBER |
| 36C24023K1006 | MCKESSON CORPORATION | Department of Veterans Affairs | $828.4M | 2023-03-01 | 2023-03-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 MARCH |
| 36C24023K1008 | MCKESSON CORPORATION | Department of Veterans Affairs | $827.19M | 2023-05-01 | 2023-05-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 MAY |
| 36C77018K0949 | MCKESSON CORPORATION | Department of Veterans Affairs | $802.27M | 2018-04-01 | 2018-06-30 | 325412 | EXPRESS REPORT: PHARMACY PRIME VENDOR CMOP FY18 APR 1, 2018 TO JUN 30, 2018 CONTRACT VA797P-12-D-0001 |
| 36C24023K1009 | MCKESSON CORPORATION | Department of Veterans Affairs | $797.63M | 2023-06-01 | 2023-06-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 JUNE |
| 36C24021K1012 | MCKESSON CORPORATION | Department of Veterans Affairs | $775.46M | 2021-09-01 | 2021-09-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 SEPTEMBER |
| 36C24022K1011 | MCKESSON CORPORATION | Department of Veterans Affairs | $765.3M | 2022-08-01 | 2022-08-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 AUGUST |
| 36C24023K1010 | MCKESSON CORPORATION | Department of Veterans Affairs | $764.46M | 2023-07-01 | 2023-07-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 JULY |
| 36C24023K1004 | MCKESSON CORPORATION | Department of Veterans Affairs | $734.59M | 2023-01-01 | 2023-01-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 JANUARY |
| 36C24023K1007 | MCKESSON CORPORATION | Department of Veterans Affairs | $727.5M | 2023-04-01 | 2023-04-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 APRIL |
| 36C24023K1003 | MCKESSON CORPORATION | Department of Veterans Affairs | $725.14M | 2022-12-01 | 2022-12-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 DECEMBER |
| 36C24022K1009 | MCKESSON CORPORATION | Department of Veterans Affairs | $716.03M | 2022-06-01 | 2022-06-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 JUNE |
| 36C24025K1004 | MCKESSON CORPORATION | Department of Veterans Affairs | $715.99M | 2025-01-01 | 2025-01-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JANUARY |
| 36C24022K1006 | MCKESSON CORPORATION | Department of Veterans Affairs | $702.92M | 2022-03-01 | 2022-03-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 MARCH |
| 36C24022K1010 | MCKESSON CORPORATION | Department of Veterans Affairs | $691.4M | 2022-07-01 | 2022-07-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 JULY |